ORIGINAL ARTICLE

Phenobarbitone, neonatal seizures, and video-EEG

G B Boylan¹, J M Rennie¹, R M Pressler², G Wilson¹, M Morton¹, C D Binnie²

¹ Neonatal Intensive Care Unit, King's College Hospital, Denmark Hill, London SE5 9RS, UK
² Department of Clinical Neurophysiology, King's College Hospital

Correspondence to:
Correspondence to:
G B Boylan, NICU, 4th Floor, Ruskin Wing, King's College Hospital, Denmark Hill, London SE5 9RS, UK;
geraldine.boylan{at}kcl.ac.uk

Aims: To evaluate the effectiveness of phenobarbitone as an anticonvulsant in neonates.

Methods: An observational study using video-EEG telemetry. Video-EEG was obtained before treatment was started, for an hour after treatment was given, two hours after treatment was given, and again between 12 and 24 hours after treatment was given. Patients were recruited from all babies who required phenobarbitone (20–40 mg/kg intravenously over 20 minutes) for suspected clinical seizures and had EEG monitoring one hour before and up to 24 hours after the initial dose. An EEG seizure discharge was defined as a sudden repetitive stereotyped discharge lasting for at least 10 seconds. Neonatal status epilepticus was defined as continuous seizure activity for at least 30 minutes. Seizures were categorised as EEG seizure discharges only (electrographic), or as EEG seizure discharges with accompanying clinical manifestations (electroclinical). Surviving babies were assessed at one year using the Griffiths neurodevelopmental score.

Results: Fourteen babies were studied. Four responded to phenobarbitone; these had normal or moderately abnormal EEG background abnormalities and outcome was good. In the other 10 babies electrographic seizures increased after treatment, whereas electroclinical seizures reduced. Three babies were treated with second line anticonvulsants, of whom two responded. One of these had a normal neurodevelopmental score at one year, but the outcome for the remainder of the whole group was poor.

Conclusion: Phenobarbitone is often ineffective as a first line anticonvulsant in neonates with seizures in whom the background EEG is significantly abnormal.

Keywords: phenobarbitone; anticonvulsant; seizure; EEG; video-EEG

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Fantoms

Martin Ward-Platt
Arch. Dis. Child. Fetal Neonatal Ed. 2002 86: F142. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Kahle, K. T., Barnett, S. M., Sassower, K. C., Staley, K. J. (2009). Decreased Seizure Activity in a Human Neonate Treated With Bumetanide, an Inhibitor of the Na+-K+-2Cl- Cotransporter NKCC1. J Child Neurol 24: 572-576 [Abstract]  
• Glass, H. C., Wirrell, E. (2009). Controversies in Neonatal Seizure Management. J Child Neurol 24: 591-599 [Abstract]  
• Sirsi, D., Nangia, S., LaMothe, J., Kosofsky, B. E., Solomon, G. E. (2008). Successful Management of Refractory Neonatal Seizures With Midazolam. J Child Neurol 23: 706-709 [Abstract]  
• Murray, D M, Boylan, G B, Ali, I, Ryan, C A, Murphy, B P, Connolly, S (2008). Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch. Dis. Child. Fetal Neonatal Ed. 93: F187-F191 [Abstract] [Full Text]  
• Clancy, R. R. (2006). Summary proceedings from the neurology group on neonatal seizures.. Pediatrics 117: S23-S27 [Abstract] [Full Text]  
• de Vries, L S, Hellstrom-Westas, L (2005). Role of cerebral function monitoring in the newborn. Arch. Dis. Child. Fetal Neonatal Ed. 90: F201-f207 [Abstract] [Full Text]  
• Castro Conde, J. R., Hernandez Borges, A. A., Martinez, E. D., Campo, C. G., Soler, R. P. (2005). Midazolam in neonatal seizures with no response to phenobarbital. Neurology 64: 876-879 [Abstract] [Full Text]  
• Rennie, J M, Chorley, G, Boylan, G B, Pressler, R, Nguyen, Y, Hooper, R (2004). Non-expert use of the cerebral function monitor for neonatal seizure detection. Arch. Dis. Child. Fetal Neonatal Ed. 89: F37-F40 [Abstract] [Full Text]